Dr. Reddy's Expands Semaglutide Portfolio With Oral Biosimilar Launch in India and Generic Injection in Canada

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.